Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating Safety and Efficacy of INtrathecal or Ommaya ReserVoir Administration of T-DXd in Patients With HER2-Expressing Breast Cancer With Active Leptomeningeal and/or Brain Metastases Based on Systemic Therapy: Phase I/II Study

NCT07134153 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT07134153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07134153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating Safety and Efficacy of INtrathecal or Ommaya ReserVoir Administration of T-DXd in Patients With HER2-Expressing Breast Cancer With Active Leptomeningeal and/or Brain Metastases Based on Systemic Therapy: Phase I/II Study
Lead sponsor
Fudan University
Phase
Phase 1/2
Overall status
Recruiting
Start date
April 18, 2025
Completion date
February 28, 2027
Enrollment
139 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer